biliary-pancreatic cancer
Conditions
Interventions
1) Intraoperative administration Direct injection of 0.2ml of ICG solution at parenchyma close to cancer with a 27-gauge needle. 2) Intraoperatice administration Intraoperative administration using
Sponsors
Jikei University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patiets who need pancreaticoduodenectomy, or distal pancreatic rescection, or bile duct resection.
Exclusion criteria
Exclusion criteria: 1) Patients with iodine allergy 2) Patients with ICG allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the number of dissected lymph node | — |
Secondary
| Measure | Time frame |
|---|---|
| the ratio of lymph node matastasis operative time intraoperative bleeding morbidity outcome | — |
Countries
Japan
Contacts
Public ContactFutagawa Yasuro
Jikei University School of Medicine Daisan Hospital Depatment of surgery
Outcome results
None listed